23.08.2013 Views

EHRA EUROPACE 2013 - European Society of Cardiology

EHRA EUROPACE 2013 - European Society of Cardiology

EHRA EUROPACE 2013 - European Society of Cardiology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

tUEsdAy 25 JUnE <strong>2013</strong> - MORNING<br />

11:00 - 12:30 symposium naxos<br />

Ablation <strong>of</strong> idiopathic ventricular tachycardias and premature ventricular<br />

complexes<br />

Chairpersons: E. Wissner (Hamburg, dE); J.-f. leclercq (levallois, fR)<br />

Clinical Practice<br />

Indication for idiopathic premature ventricular complexes/ventricular tachycardias ablation in usual<br />

practice but also from rare sites <strong>of</strong> origin<br />

11:00 When to ablate patients with high density premature ventricular complexes? 772<br />

H. Kottkamp (Zurich, CH)<br />

11:22 Ablation <strong>of</strong> ventricular tachycardias arising from the right ventricular outflow tract,<br />

left ventricular outflow tract and aortic cusps. 773<br />

F. Ouyang (Hamburg, DE)<br />

11:45 Ablation <strong>of</strong> ventricular tachycardias arising from the papillary muscle, the tricuspid<br />

and mitral annulus. 774<br />

D.J. Wilber (Maywood, US)<br />

12:07 Ablation fo ventricular tachycardias/premature ventricular complexes arising from<br />

the great cardiac veins and epicardial sites. 775<br />

A. Natale (Austin, US)<br />

11:00 - 12:30 special session lefkada<br />

Debated issues in channelopathies<br />

Genetic summit<br />

Chairpersons: P. Kirchh<strong>of</strong> (birmingham, Gb); H. Abriel (bern, CH)<br />

basic science<br />

11:00 From in silico to in vitro characterisation <strong>of</strong> mutations: what is most helpfl for the clinician? 776<br />

P.G.A. Volders (Maastricht, NL)<br />

11:22 next generation sequencing: lights and shadows for its use in clinical diagnosis. 777<br />

J. Ware (London, GB)<br />

11:45 Epicardial ablation in Brugada Syndrome: ready for prime time? 778<br />

K. Nademanee (Los Angeles, US)<br />

12:07 induced pluripotent stem cells derived myocytes: immature cells or suitable models<br />

for channelopathies? 779<br />

E. Cerbai (Florence, IT)<br />

117<br />

tuesday<br />

sessions

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!